ARS Pharmaceuticals (SPRY) Institutional Ownership

$8.80 -0.10 (-1.11%)

As of 02:49 PM Eastern

Current Institutional Ownership Percentage: 68.16%
Number of Institutional Buyers (last 12 months): 120
Total Institutional Inflows (last 12 months): $407.84M

Number of Institutional Sellers (last 12 months): 53
Total Institutional Outflows (last 12 months): $96.71M

Get SPRY Insider Trade Alerts

Want to know when executives and insiders are buying or selling ARS Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SPRY Institutional Buying and Selling by Quarter

ARS Pharmaceuticals Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/27/2026	Alpine Woods Capital Investors LLC	10,000	$80K	0.0%	N/A	0.010%
5/19/2026	Bank of America Corp DE	285,728	$2.29M	0.0%	-40.7%	0.288%
5/18/2026	ADAR1 Capital Management LLC	1,361,536	$10.93M	0.6%	+268.4%	1.371%
5/18/2026	Rubric Capital Management LP	8,000,000	$64.24M	0.7%	+29.0%	8.056%
5/18/2026	Eversept Partners LP	136,235	$1.09M	0.1%	-45.9%	0.137%
5/16/2026	The Manufacturers Life Insurance Company	16,637	$134K	0.0%	-48.1%	0.017%
5/16/2026	Quantinno Capital Management LP	101,412	$814K	0.0%	+90.9%	0.102%
5/14/2026	Sei Investments Co.	12,983	$104K	0.0%	-82.6%	0.013%
5/13/2026	Levin Capital Strategies L.P.	552,561	$4.44M	0.3%	-26.1%	0.556%
5/13/2026	First Trust Advisors LP	422,038	$3.39M	0.0%	N/A	0.425%
Get the Latest News and Ratings for SPRY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ARS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
5/7/2026	Investment Management Associates Inc. ADV	359,074	$2.88M	0.7%	+15.3%	0.362%
5/7/2026	Dimensional Fund Advisors LP	172,339	$1.38M	0.0%	-2.1%	0.174%
5/6/2026	Bessemer Group Inc.	7,525	$61K	0.0%	+3,102.1%	0.008%
5/4/2026	Empirical Financial Services LLC d.b.a. Empirical Wealth Management	31,568	$253K	0.0%	+46.1%	0.032%
5/1/2026	General American Investors Co. Inc.	727,154	$5.84M	0.4%	+29.9%	0.732%
4/30/2026	Kestra Advisory Services LLC	40,920	$329K	0.0%	+1,079.3%	0.041%
4/27/2026	Private Advisor Group LLC	30,242	$243K	0.0%	-3.9%	0.030%
4/27/2026	Y Intercept Hong Kong Ltd	15,924	$128K	0.0%	N/A	0.016%
4/22/2026	Janney Montgomery Scott LLC	2,016,464	$16.19M	0.0%	+56.6%	2.031%
3/24/2026	Creek Drive Management Group LLC	295,863	$3.45M	2.4%	N/A	0.298%
2/25/2026	Sit Investment Associates Inc.	92,875	$1.08M	0.0%	+24.6%	0.094%
2/19/2026	Invesco Ltd.	37,230	$434K	0.0%	-7.2%	0.038%
2/18/2026	Creek Drive Management Group LLC	295,863	$3.45M	2.6%	N/A	0.299%
2/18/2026	FAS Wealth Partners Inc.	202,407	$2.36M	0.2%	+0.9%	0.205%
2/18/2026	Coastal Bridge Advisors LLC	53,830	$627K	0.0%	-41.3%	0.054%
2/18/2026	XTX Topco Ltd	37,201	$433K	0.0%	-74.1%	0.038%
2/18/2026	VARCOV Co.	22,300	$260K	0.1%	N/A	0.023%
2/18/2026	Osterweis Capital Management Inc.	5,610	$65K	0.0%	N/A	0.006%
2/18/2026	Millennium Management LLC	3,168,406	$36.91M	0.0%	N/A	3.205%
2/18/2026	Eversept Partners LP	251,593	$2.93M	0.1%	-74.2%	0.255%
2/18/2026	Boothbay Fund Management LLC	201,474	$2.35M	0.0%	-1.5%	0.204%
2/17/2026	Freestone Grove Partners LP	28,003	$326K	0.0%	-81.6%	0.028%
2/17/2026	ADAR1 Capital Management LLC	369,569	$4.31M	0.3%	+524.0%	0.374%
2/17/2026	Third Point LLC	556,237	$6.48M	0.1%	N/A	0.563%
2/17/2026	Cetera Investment Advisers	15,340	$179K	0.0%	N/A	0.016%
2/17/2026	Lazard Asset Management LLC	14,347	$167K	0.0%	N/A	0.015%
2/17/2026	Trexquant Investment LP	150,100	$1.75M	0.0%	-76.2%	0.152%
2/17/2026	Wealth Architects LLC	10,000	$116K	0.0%	N/A	0.010%
2/17/2026	FIL Ltd	810,073	$9.44M	0.0%	N/A	0.820%
2/17/2026	Tannin Capital LLC	13,066	$152K	0.1%	N/A	0.013%
Your $29.97 book is free today (Ad) Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account. Normally $29.97. Today it's free. Grab your copy now.
2/17/2026	California State Teachers Retirement System	54,098	$630K	0.0%	+21.9%	0.055%
2/17/2026	Diker Management LLC	33,508	$390K	0.3%	-23.0%	0.034%
2/17/2026	Royal Bank of Canada	4,684	$54K	0.0%	-87.7%	0.005%
2/17/2026	Blair William & Co. IL	11,600	$135K	0.0%	N/A	0.012%
2/16/2026	General American Investors Co. Inc.	559,959	$6.52M	0.4%	N/A	0.566%
2/16/2026	Barclays PLC	196,387	$2.29M	0.0%	-14.1%	0.199%
2/13/2026	Kestra Advisory Services LLC	3,470	$40K	0.0%	-92.9%	0.004%
2/13/2026	Marshall Wace LLP	79,214	$923K	0.0%	-59.9%	0.080%
2/13/2026	Quinn Opportunity Partners LLC	155,000	$1.81M	0.1%	+24.0%	0.157%
2/13/2026	Rubric Capital Management LP	6,200,000	$72.23M	0.9%	+37.8%	6.272%
2/13/2026	Rafferty Asset Management LLC	115,564	$1.35M	0.0%	-5.6%	0.117%
2/13/2026	Alyeska Investment Group L.P.	418,883	$4.88M	0.0%	+7.4%	0.424%
2/13/2026	Charles Schwab Investment Management Inc.	550,932	$6.42M	0.0%	+5.8%	0.557%
2/13/2026	State Street Corp	3,223,581	$37.56M	0.0%	+11.3%	3.261%
2/13/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	304,445	$3.55M	0.0%	-9.2%	0.308%
2/13/2026	Wealthspire Advisors LLC	23,650	$276K	0.0%	N/A	0.024%
2/12/2026	HRT Financial LP	68,645	$799K	0.0%	N/A	0.069%
2/12/2026	Dimensional Fund Advisors LP	176,122	$2.05M	0.0%	-1.1%	0.178%
2/12/2026	Steward Partners Investment Advisory LLC	216,296	$2.52M	0.0%	+47.4%	0.219%
2/12/2026	Bank of Montreal Can	643,407	$7.50M	0.0%	N/A	0.651%
2/12/2026	Alps Advisors Inc.	81,168	$946K	0.0%	+63.6%	0.082%
2/12/2026	Swiss National Bank	107,200	$1.25M	0.0%	+27.2%	0.108%
2/11/2026	Janney Montgomery Scott LLC	1,287,832	$15.00M	0.0%	+6.2%	1.303%
2/11/2026	Deutsche Bank AG	48,727	$568K	0.0%	+16.2%	0.049%
2/11/2026	Fox Run Management L.L.C.	38,587	$450K	0.1%	N/A	0.039%
2/11/2026	Franklin Resources Inc.	2,543,097	$29.63M	0.0%	+6.1%	2.573%
2/11/2026	Schulhoff & Co. Inc.	51,150	$596K	0.3%	+17.6%	0.052%
2/11/2026	CenterBook Partners LP	568,361	$6.62M	0.3%	+10.9%	0.575%
2/11/2026	JPMorgan Chase & Co.	417,090	$4.86M	0.0%	+262.5%	0.422%
2/11/2026	Los Angeles Capital Management LLC	65,746	$766K	0.0%	N/A	0.067%
2/10/2026	Goldman Sachs Group Inc.	812,036	$9.46M	0.0%	-38.7%	0.821%
2/10/2026	Intech Investment Management LLC	22,626	$264K	0.0%	-28.2%	0.023%
2/9/2026	Geode Capital Management LLC	1,552,870	$18.09M	0.0%	+3.1%	1.571%
2/9/2026	Knights of Columbus Asset Advisors LLC	130,729	$1.52M	0.1%	-2.8%	0.132%
2/9/2026	Royce & Associates LP	207,051	$2.41M	0.0%	N/A	0.209%
2/9/2026	Sectoral Asset Management Inc.	29,803	$347K	0.3%	-63.6%	0.030%
2/9/2026	Lisanti Capital Growth LLC	396,509	$4.62M	1.1%	+87.8%	0.401%
2/6/2026	Legato Capital Management LLC	109,095	$1.27M	0.1%	+176.8%	0.110%
2/6/2026	Nano Cap New Millennium Growth Fund L P	25,000	$291K	0.2%	N/A	0.025%
2/6/2026	ProShare Advisors LLC	15,139	$176K	0.0%	+11.3%	0.015%
2/4/2026	Empire Life Investments Inc.	352,602	$4.11M	0.2%	-0.9%	0.357%
2/3/2026	Investment Management Associates Inc. ADV	311,503	$3.63M	1.0%	N/A	0.315%
2/3/2026	AssuredPartners Investment Advisors LLC	75,779	$883K	0.1%	+31.1%	0.077%
2/2/2026	Oppenheimer & Co. Inc.	17,858	$208K	0.0%	+42.7%	0.018%
1/30/2026	Levin Capital Strategies L.P.	747,506	$8.71M	0.8%	-2.2%	0.756%
1/30/2026	Torren Management LLC	2,762	$32K	0.0%	N/A	0.003%
1/29/2026	Pictet Asset Management Holding SA	10,362	$121K	0.0%	-94.5%	0.010%
1/29/2026	Matisse Capital	55,561	$647K	0.3%	-3.9%	0.056%
1/29/2026	UBS Group AG	2,210,866	$25.76M	0.0%	+235.0%	2.237%
1/29/2026	China Universal Asset Management Co. Ltd.	16,107	$188K	0.0%	-7.0%	0.016%
Your $29.97 book is free today (Ad) Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account. Normally $29.97. Today it's free. Grab your copy now.
1/28/2026	Arizona State Retirement System	15,372	$179K	0.0%	+17.6%	0.016%
1/26/2026	Mirae Asset Global Investments Co. Ltd.	4,803	$56K	0.0%	+25.7%	0.005%
1/16/2026	Aberdeen Group plc	3,556,049	$41.43M	0.1%	+14.8%	3.597%
1/16/2026	Empirical Financial Services LLC d.b.a. Empirical Wealth Management	21,614	$252K	0.0%	N/A	0.022%
1/9/2026	SG Americas Securities LLC	76,203	$888K	0.0%	+654.1%	0.077%
1/7/2026	Permanent Capital Management LP	52,306	$609K	0.1%	-1.9%	0.053%
11/17/2025	Woodline Partners LP	150,936	$1.52M	0.0%	-49.8%	0.153%
11/17/2025	Dark Forest Capital Management LP	50,940	$512K	0.0%	N/A	0.052%
11/17/2025	XTX Topco Ltd	143,636	$1.44M	0.1%	+740.3%	0.145%
11/17/2025	Alyeska Investment Group L.P.	390,092	$3.92M	0.0%	+34.5%	0.395%

SPRY Institutional Ownership - Frequently Asked Questions

During the previous two years, 198 institutional investors and hedge funds held shares of ARS Pharmaceuticals. The most heavily invested institutionals were Deerfield Management Company L.P. Series C ($110.93M), Deerfield Management Company L.P. ($75.41M), Rubric Capital Management LP ($64.24M), Aberdeen Group plc ($41.43M), State Street Corp ($37.56M), Millennium Management LLC ($36.91M), and Vanguard Group Inc. ($35.18M).Learn more on ARS Pharmaceuticals' institutional investors.

68.16% of ARS Pharmaceuticals' stock is owned by institutional investors. Learn more on SPRY's institutional investor holdings.

Of the 180 institutional investors that purchased ARS Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Rubric Capital Management LP ($6.97M), Alliancebernstein L.P. ($3.85M), Millennium Management LLC ($3.62M), Aberdeen Group plc ($3.56M), Adage Capital Partners GP L.L.C. ($1.73M), Casdin Capital LLC ($1.60M), and UBS Group AG ($1.55M).

Institutional investors have bought a total of 35,048,537 shares in the last 24 months. This purchase volume represents approximately $407.84M in transactions.

Of the 53 institutional investors that sold ARS Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Deerfield Management Company L.P. ($2.22M), Alliancebernstein L.P. ($1.28M), Eversept Partners LP ($840.28K), Goldman Sachs Group Inc. ($513.70K), Trexquant Investment LP ($481.62K), Barclays PLC ($425.85K), and Bank of America Corp DE ($369.03K).

Institutional investors have sold a total of 8,752,739 shares in the last 24 months. This volume of shares sold represents approximately $96.71M in transactions.

Related Companies

This page (NASDAQ:SPRY) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ARS Pharmaceuticals (SPRY) Institutional Ownership

SPRY Institutional Buying and Selling by Quarter

ARS Pharmaceuticals Major Shareholders & Ownership History

SPRY Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ARS Pharmaceuticals (SPRY) Institutional Ownership

Institutional Ownership Changes (13F Filings) for ARS Pharmaceuticals (NASDAQ:SPRY)

SPRY Institutional Buying and Selling by Quarter

ARS Pharmaceuticals Major Shareholders & Ownership History

SPRY Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of SPRY shares?

What percentage of ARS Pharmaceuticals' stock is owned by institutional investors?

Which institutional investors have been buying ARS Pharmaceuticals' stock?

How much institutional buying is happening at ARS Pharmaceuticals?

Which of ARS Pharmaceuticals' major shareholders have been selling company stock?

How much institutional selling is happening at ARS Pharmaceuticals?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools